Latest News about MGNX
Recent news which mentions MGNX
Why MacroGenics Stock Is Sinking Today
February 25, 2022
From Motley Fool
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Monday
February 14, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 4, 2022
February 04, 2022
From Benzinga
The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
November 02, 2021
From Benzinga
Earnings Scheduled For November 2, 2021
November 02, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2021
October 19, 2021
From Benzinga
From Benzinga
3 Stocks Insiders Are Buying
October 01, 2021
From Benzinga
Why Are I-Mab Shares Trading Higher On Tuesday?
September 28, 2021
From Benzinga
Notable Insider Buys Of The Past Week Include Designer Brands, MacroGenics And More
September 25, 2021
From Benzinga
56 Biggest Movers From Yesterday
September 17, 2021
From Benzinga
Mid-Afternoon Market Update: Dow Falls 70 Points; Aerie Pharmaceuticals Shares Plunge
September 16, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
September 16, 2021
From Benzinga
Mid-Day Market Update: Gold Drops Over 2%; Leap Therapeutics Shares Jump
September 16, 2021
From Benzinga
38 Stocks Moving In Thursday's Mid-Day Session
September 16, 2021
From Benzinga
Mid-Morning Market Update: Markets Down; US Retail Sales Unexpectedly Increase in August
September 16, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
September 16, 2021
From Benzinga
The Week Ahead In Biotech (Sept. 12-18): Calliditas FDA Decision, Adcom Review For Pfizer/BioNTech COVID-19 Vaccine, Oncology Conference And IPOs
September 12, 2021
From Benzinga
Why MacroGenics Soared Nearly 9% Higher Today
September 09, 2021
From Motley Fool
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
September 08, 2021
From Benzinga
MacroGenics' Cancer Drug Margenza Flops On Overall Survival Analysis
September 08, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
|
|
|